Public sector borrowers have been sidelined in US dollars by a perilously uncertain backdrop, with total volumes raised this month only a fraction relative to previous years. Market participants now ...

Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its ...

The Exchange accepts no responsability for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it. By allowing this ...